Patent Application
20160331699
The present invention relates to a carotenoid compound coming from plant extract with less impurity containing natural astaxanthin with high biological activities, and its preparation method and composition, and relates to the field of biochemistry.
Astaxanthin's formula is C40H52O4 and is referred to as 3,3′-dihydroxy-4,4′-diketo-β,β′-carotene, widely exists in nature, is an important substance of carotenoid, and has a higher physiological activity than other carotenoids. The molecular formula is as follows:
As for a kind of natural preparation, astaxanthin has broader uses and development prospects in various industries such as pharmaceuticals, aquaclutures, foods, chemistries.
Astaxanthin plays a role in the body without being transformed into vitamin A, and has various excellent biological functions such as protecting retinas and central nervous systems, preventing UV radiation, preventing cardiovascular disease and enhancing immunity of organism etc. as for a kind of non-vitamin A source carotenoid.
First of all, astaxanthin is referred to as “super VE” and is substances with the most oxidizability so far, and is 1000 times as much as that of natural VE. Its molecular structure has long conjugated double bonds, and is coupled with a α-ketone hydroxyl composed of unsaturated keto group and hydroxyl at the end of carbon chain, and has lively electronic effects, to make astaxanthin easily react with radicals and clear them, and has strong antioxidant properties. Double blind human assays have proven that astaxanthin contributes to improve antioxygenic property of erythrocyte and reduce levels of phospholipid hydroperoxide.
At the same time, it is shown from immunological research that astaxanthin has a stronger ability of inhibiting cancer than that of β-carotene, can directly act on immune systems and induce tumor shrinkage. Astaxanthin has functions of improving anti-tumor immune response and reducing incidences of various cancers in mice such as gastric cancer, colon cancer, oral cancer and bladder cancer in a certain extent, reducing carcinogenicity of aflatoxin, and preventing from skin aging and skin cancer caused by light radiation as for a light protective agent.
Furthermore, astaxanthin has high immunomodulatory activities and promotes production of human immunoglobulins. Astaxanthin can effectively prevent from occurrence and spread of diseases after combining with its antioxidant function. Feeding astaxanthin can enhance antibody responses and humoral immunity, slow down reductions of immune ability, enhance functions of T cells in vivo, increase numbers of neutrophils, and participate in organism cellular immunity. Assays show that feeding astaxanthin can enhance antibody responses and humoral immunity, improve immunity of animals; enhance cellular immunity responses and humoral immune responses of dogs and reduce DNA damage and inflammation.
In addition, astaxanthin itself is bright red, and is the end of carotenoid synthesis in vivo, and has strong abilities of pigmentation. Astaxanthin can be directly stored and deposited in tissue without modification or biochemical conversion, and can be used as a functional pigment in various industrial fields after entering animal body. It is shown from a large number of animal assays that adding appropriate astaxanthin in baits can improve colors of skin and muscle, and enhance ornamental values and commodity values of aquatic animals. It may be found from feeding astaxanthin of euphausia superba and opossum shrimp into the red carp that the pigmentation effect on fish skin is obvious and maintained.
Furthermore, astaxanthin also can enhance survival rates of fishes and shrimps, reduce infectious diseases, promote early embryonic developments; and have functions such as keeping fresh and preventing discoloration, off-flavor and metamorphism in food industry. It also can be applied in fields of cosmetics, because of its effects such as anti-oxidation, anti-wrinkle and anti-ultraviolet radiation. Astaxanthin is remarkably the only substance to effectively prevent from diabetic kidney damage. It has been found from several studies that astaxanthin also can prevent diseases such as arteriosclerosis, cataracts, cardiovascular disease, and used as nutritional supplements.
Astaxanthin has multiple double bonds in its molecular structural formula, correspondingly has cis- and trans-isomers. Generally speaking, all trans-isomers astaxanthin has the highest activity relative to cis-isomers, astaxanthin has two isomers as 9-cis and 13-cis, because of influences of spatial structure.
In addition, due to four chiral centers existing in its molecular structural formula, astaxanthin also has optical isomers. The main optical isomer includes three forms such as (3 R, 3 R)′—, (3 R, 3 S,′ meso)- and (3 S, 3′S)—, and the molecular structure of the three isomers are shown below. Different sources of astaxanthin give different optical isomers. Different optical isomers have different physiological activities. Generally speaking, the bioavailability of (3 S, 3′S)-configuration in animal body is relatively high and is 15 wt % higher than the bioavailability of (3 R, 3 R)′-configuration. The molecular structural formula of astaxanthin of salmon is (3 S, 3 ′S)-configuration.
At present, astaxanthin is mainly produced in two ways such as chemical synthesis and natural extraction. Astaxanthin prepared by chemical synthesis is expensive and has significant differences in molecular structures, biological functions, application effects and biological safeties. Synthetic astaxanthin is a mixture of three different configurations wherein most of them are (3R and 3′S). Synthetic astaxanthin obviously has stability and antioxidant activity lower than that of natural astaxanthin, and the effects of biological absorption and pigmentation of synthetic astaxanthin are also worse than that of natural astaxanthin. And synthetic astaxanthin can not be converted into natural astaxanthin in animal bodies. On the other hand, pollutions and impurities are inevitably produced in the process of synthesis, which can lead to generation of some potential safety hazard and reduction of safety performance.
Natural astaxanthin often combines with protein in vivo to show different colors such as green and brown. Astaxanthin released is bright red after protein denaturation by heating. Its molecular formula has a hydroxyl group which easily combines with carboxyl to generate stable astaxanthin esters. Therefore most of natural astaxanthin exists in the states of astaxanthin esters, such as monadic ester, dibasic ester.
There are six sources from extraction of crustaceans animals and plants such as bacteria, protozoa, fungi, microalgae in natural astaxanthin. Wherein the bacteria thalli has basically no use value because of its slow growth and low synthesis. And astaxanthin of protozoa is not synthesized by itself, and consequently is not considered.
It have been reported from domestic and international literature that producing astaxanthin from microalgae is to culture product of haematococcus pluvialis. Natural astaxanthin obtained by the method has with predominance of (3S, 3′S)-configuration, has basically the same molecular structure of astaxanthin as that of salmon organisms, and has higher activity. However, it is difficult to establish a stable and efficient production technology system, because the Haematococcus pluvialis is sensitive to environment, and susceptible to protozoa and bacterial contamination.
Astaxanthin can be accumulated and cultured from products of some fungi such as Phaffia rhodozyma. It would be required to add a lot of carbon sources and nitrogen sources, especially has high price organic nitrogen source (yeast extract and peptone, etc.) so as to improve astaxanthin yields of Phaffia rhodozyma and overcome disadvantages of low content. Consequently it increases production costs and is adverse to commercial production. At present, studies on industrial production of astaxanthin by uses of fungi focus on breeding of high-yield strain, exploration on fermentation process and regularity, studies on cheap fermentation substrates and its physiological function, etc.
Many factors restrict astaxanthin extraction including shellfish waste such as shrimp shell being perishable, large volume, relatively high transportation cost, low content levels of astaxanthin with large changes, binding state of astaxanthin, particle size shell, etc. No better method with industrial scales of producing astaxanthin from these wastes has been found at present.
Currently, natural astaxanthin is mainly obtained by culture of Haematococcus pluvialis, fermentation of Phaffia rhodozyma, and extraction of aquatic products such as shrimp and crab. However, it would be difficult to realize large-scale production because of some deficiencies such as culture conditions, high costs, and difficult extraction conditions. It should be noted that some plants also contain astaxanthin and carotene ketone, in particular, for the genus ranunculaceae plants such as Adonis amurensis, Adonis vernalis, Adonis aestivalis, Adonis palaestinia, besides animals and microorganisms. Petals of Ranunculaceae Adonis genus also contain a large amount of astaxanthin. To extract natural astaxanthin by planting a large amount of Adonis amurensis with high-content of natural astaxanthin is an up-and-coming method.
Production of natural astaxanthin by extracting from plant tissue such as Adonis amurensis (also called “adonis”) is an up-and-coming method and is different from production method by culture of algae, fermentation of fungus, and extraction of shellfish. On the one hand, natural astaxanthin obtained by this method has high activity, and its molecular structure of astaxanthin is basically consistent with that of astaxanthin in organisms of salmon. On the other hand, cultivation condition of Adonis amurensis is simple, to be easy to realize large-scale cultivation and realize industrial production.
Adonis amurensis (scientific name: Adonis amurensis), another name false hellebore or adonis aestivalis, is a perennial herbaceous plant of the Adonis genus, and is mainly distributed in northeast China, South Korea, Japan, and Siberia. The flowering phase is a cold period of early spring from February to April. Most of Adonis amurensis are basically yellow flowers with 3 cm to 4 cm, flower diameter modified by gene may have an increased diameter. Most of Adonis amurensis of European varieties are red flowers, other varieties are green, white, orange and double flowers. Adonis amurensis contains natural astaxanthin, wherein the content of astaxanthin in the dried flower is about 2 wt %.
Carotenoid of Adonis amurensis contains 75-90 wt % of monoester, diester or free astaxanthin, 5˜10 wt % of lutein and adonirubin, and less than 1 wt % of 3-hydroxyechinenone, 4-hydroxyechinenone and β-carotene, etc.
Generally carotenoid is extracted from Adonis amurensis by organic solvents or a super critical method to obtain adonis oleoresin (also called an “adonis extractum”) containing less than 10 wt % of astaxanthin, and astaxanthin in oleoresin also exists in the form of diester or monoester. As mentioned above, the bioavailability of astaxanthin in esterified state can be affected in the animal body. It is necessary to obtain free natural astaxanthin by saponifying astaxanthin. Astaxanthin is a very unstable substance, with high antioxidant activity, and is very easily oxidized to semi-astacene under the conditions of alkaline environment or oxygen or heating, thereby affecting its bioactivity. The molecular structural formula of semi-astacene and astacene are shown in the figures below:
Semi-astacene and astacene also belong to the class of carotenoids, some aquatic animals such as shrimp and crab show cyan when alive and show red after cooking. This is because astaxanthin of shrimp and crab is changed to semi-astacene and astacene after heating. There are large number amounts of semi-astacene and astacene in the human diet, and a relatively large amount of semi-astacene and astacene exists in human blood without security problem. Its antioxidant activity is reduced when astaxanthin is oxidized to semi-astacene and astacene. One should try to prevent changing from astaxanthin to semiastacene or atacene during processing if astaxanthin is used as a dietary supplement or a coloring agent.
So some conditions such as the appropriate solvent, alkali concentration, saponification time, reaction temperature and substrate concentration must be controled in the process of hydrolyzing astaxanthin diester into free astaxanthin, to maintain a balance of reaction and reduce generation of semiastacene and atacene in the reaction process, to keep strong antioxidant activity of astaxanthin products.
Alternately, there are other carotenoids such as adonirubin, lutein, and echinenone besides astaxanthin in carotenoid of adonis amurensis. These carotenoids are found in daily dietary composition and in human blood. But these carotenoids should be removed in the process of extraction and purification of astaxanthin, in order to improve the proportion of astaxanthin in the total carotenoid.
In previous literature, it was reported that natural astaxanthin was extracted from Adonis amurensis. US2006/0260010A1 discloses plantation of a new modified plant of Adonis palaestina to increase astaxanthin content of flowers, and methods of extracting astaxanthin from flowers. The application in more detail describes variety improvement of Adonis amurensis, flower characteristics, contents of harmful material composition of cardenolide, forms of astaxanthin in flowers and compositions of other carotenoid, and wherein describes that contents of Adonis oleoresin containing astaxanthin obtained by supercritical CO2 extraction is 5 wt %˜10 wt % and the purity of the product is not high. However, it was not mentioned how to remove impurities in Adonis oleoresin or Astaxanthin crystal containing Astaxanthin.
U.S. Pat. No. 5,453,565 revealed a method of extracting astaxanthin from Adonis amurensis by cultivating Adonis amurensis genus having at least 16 petals per flower head. The product obtained by the method is in Adonis amurensis oleoresin form, and the Adonis amurensis oleoresin containing low levels of astaxanthin are purified by silica gel column chromatography to obtain 20 wt % of the total carotenoid containing 80 wt % astaxanthin in the form of fatty acid ester in the product.
Chinese patent CN101863812A also discloses a method of preparing ointments containing astaxanthin by extracting Adonis dried flower with a mixture of solvent of propane and butane, and purifying the ointments by use of a silica gel column to obtain a product with high purity. The astaxanthin of the product is also in the form of fatty acid ester.
Chinese patent CN 1234687C described a method of extracting astaxanthin from Adonis amurensis to obtain 5 wt % of the total carotenoid in the final dried product, and 80 wt % of astaxanthin fatty acid ester in the total carotenoid.
The above-mentioned published applications or patents mainly relate to improvement of plant species to improve astaxanthin contents in the flowers, or processes of extracting Adonis amurensis oleoresin with lower levels of astaxanthin from Adonis amurensis, purifying Adonis amurensis oleoresin by silica gel column chromatography to finally obtain low levels of the total carotenoid with content of 5˜10 wt %, without research or definition for carotenoid with lower activity.
On the other hand, the bioavailability of free astaxanthin is higher than that of astaxanthin in the form of fatty acid ester in vivo, is generally higher than 15% (Johnson and the An. Crit. Rev. Biotechnol, 1991). So it would improve the bioavailability of astaxanthin if the astaxanthin fatty acid ester is saponified to free astaxanthin. On the other hand, these impurities including other carotenoid should be removed in the process of saponification of astaxanthin fatty acid and subsequent purification. Especially the appropriate reaction conditions should be selected to reduce semi-astacene and Astacene, to maintain antioxidant activities of astaxanthin.
The present invention provides a carotenoid compound coming from plants containing natural astaxanthin and a preparation method thereof to overcome the deficiencies of the prior art.
According to one aspect of the present invention, the present invention provides a high-content carotenoid compound from flower, stem and fruit of adonis amurensis, the content of the total carotenoid in the high-content carotenoid compound is higher than 95 wt %, wherein the proportion of all-trans (3S, 3′S)-astaxanthin in the total carotenoid is higher than 80 wt %, the all-trans (3S, 3′S)-astaxanthin has the molecular structure as shown in formula (I):
Preferably, the high-content carotenoid comprises semi-astacene, astacene and adonirubin.
Preferably, in the high-content carotenoid compound, the proportion of the total content of semi-astacene and astacene in the total carotenoid is less than 10 wt %, and the proportion of adonirubin in the total carotenoid is less than 10 wt %.
According to another aspect of the present invention, the present invention provides a method of preparing a high content carotenoid compound by using adonis amurensis extract as the starting raw material, and the method comprises the following steps:
(a) mixing adonis amurensis extract with an alcohol(s) solvent and fully dissolving the extract to obtain a mixed solution;
(b) heating the mixed solution of step (a) to 25˜75° C., and dropwise adding an alkali solution to the reaction, with the reaction time being 0.5˜6.0 hr;
(c) adding a mixture of alcohol(s) solvent and water to obtain a reaction solution, after completion of step (b);
(d) filtering the reaction solution of step (c) to obtain a filter cake, and then washing the filter cake with a mixture of alcohol(s) solvent and water; and
(e) drying the filter cake of step (d) in vacuum to obtain a carotenoid compound;
wherein in the high-content carotenoid compound, the content of the total carotenoid is higher than 95 wt %, the proportion of the all-trans (3S, 3′S) astaxanthin in the carotenoid is higher than 80 wt %, the all-trans (3S, 3′S)-astaxanthin has the molecular structure as shown in formula (I):
Preferably, the alcohol(s) solvent of the step (a) is ethanol, propylene glycol or glycerol. The alcohol(s) solvent is beneficial to dissolution of astaxanthin fatty acid ester of the reaction substrates, the astaxanthin of the reaction product has low solubility in the alcohol(s) solvent, in order to facilitate the reaction and precipitate carotenoid crystals in the reaction process after completion of the reaction.
Preferably, the ratio of volume of the alcohol(s) solvent to the weight of Adonis amurensis extract in step (a) is 5˜50 times. More preferably, the ratio of volume of the alcohol(s) solvent to the weight of Adonis amurensis extract in step (a) is 25˜40 times. If an amount of the solvent is too great, it is adverse to the reaction and prolongs the reaction time and increases amounts of alkali. If an amount of the solvent is too small, a concentration of the reaction is too high. More importantly, increasing concentration of the alkali in the reaction system generates more impurities, and which is adverse to improving the purity of the final products.
Preferably, the alkali solution in step (b) is a sodium hydroxide solution, potassium hydroxide solution or sodium methoxide solution.
Preferably, the concentration of the alkali solution of the reaction mixture in step (b) is 0.01˜2.50 mol/L after completion of adding dropwise the alkali solution. More preferably, the concentration of the alkali solution of the reaction mixture in step (b) is 1.00˜2.00 mol/L after completion of adding dropwise the alkali solution. The alkali concentration of the reaction system is critical, because firstly the saponification is not complete if the alkali concentration is low, and it takes a long reaction time; secondly, it is easy to produce oxidation of astaxanthin to semi-astancene and atacene, to reduce purities of astaxanthin in final products if alkali concentration is too high. Consequently, the alkali concentration of the reaction system of the present invention is 0.01˜2.50 mol/L, preferably, 1.00˜2.00 mol/L. Some general separation measures such as using filter aids, changing the acidity-basicity and other measures in the process are used for increasing separation efficiency.
Preferably, the volume ratio of alcohol(s) solvent to water in step (c) is 1:5˜10. Preferably, the volume ratio of alcohol(s) solvent to water in step (d) is 2˜3:1. The content of the total carotenoid and proportion of astaxanthin therein in the final product may be adjusted by adjusting the proportion of alcohol(s) solvent to water and their total amount. The more the usage of the mixture solution, the higher the percentage of alcohol(s) solvent, and then the higher the total carotenoid content is in the final product, and the higher the proportion of astaxanthin is in the final product. But it affects yields of the final product.
According to another aspect of the present invention, the present invention provides a composition comprising the high content carotenoid compound for the preparation of foods, feed additives, dietary supplements, and cosmetics. Preferably, the composition further comprises of the group consisting of vegetable oils, modified starch, sucrose, dextrin, and other food accessories.
The application form of astaxanthin may be in the form of oil, that is, the astaxanthin is dispersed in vegetable oil. And the application form of astaxanthin also may be in the form of powder, that is, after mixing with one or more selected from gelatin, modified starch, dextrin, sucrose and other auxiliary materials, the astaxanthin is embedded by a microcapsule emulsion technology in order to obtain astaxanthin in the form of microcapsule powder with good stability.
It may be seen from it that the preparation method of the high content carotenoid compound by using Adonis amurensis as the raw material of the present invention only relates to a saponification, and then after the saponification, washing with a mixture of water and ethanol for several times to remove impurities in the amorphous state to obtain a carotenoid compound containing astaxanthin, and further obtains a high content carotenoid compound by vacuum drying. No additional crystallization and purification steps are used in the whole process and no silica gel column chromatography process as reported by the prior art is used. Most of other carotenoid impurities are removed, the content of semi-astacene and atacene is little and the final product maintains high biological activity. So the process is suitable for industrial production.
Thus the content determined by UV spectrophotometry is higher than 95 wt %, often higher than 97 wt %, and the content of all trans (3 S, 3 S)-astaxanthin analyzed by HPLC is higher than 80 wt %, and the remainders are calendulin, semi-astacene, astacene, echinenone or hydroxyechinenone, in the carotenoid compound obtained by the method of the present invention. These carotenoids are dietary sources and can be detected in human blood, and no security risk is present in the content. Also, no safety issues are present in the products because ethanol is only used as solvents of the process, without uses of any other toxic and harmful organic solvent, and without other chemical impurities. Besides, the method is convenient to operate, and suitable for large-scale commercial production, because no additional purification steps such as column separation or multiple recrystallization steps are used in the process besides a one step reaction.
Hereafter, the present invention will be described specifically with reference to examples. The examples are given only for illustration of the technical solution of the present invention and should not be construed to limit the present invention.
Firstly, the detection method of total carotenoid content in the crystals of the present invention is that measured by determining the content of the total carotenoid by ultraviolet-visible spectrophotometry (UV). Twenty (20) mg samples to be tested are weighed and added into a 100 ml brown volumetric flask, and 10 ml of chloroform are added to the brown volumetric flask to dissolve, and then n-hexane is added to constant volume, and shaken well to obtain a mixture solution. One (1) ml of the mixture solution is added to a 100 ml volumetric flask, then 4 ml of chloroform is added to the flask, then hexane is added to constant volume to a scale. The absorbance value of the solution is determined at 470 nm by ultraviolet-visible absorption photometer, and n-hexane is used as a blank.
The content C of the total carotenoid is C=A*10000/(2100*W), wherein A is an absorbance and W is sample weight.
In addition, the condition of detecting a proportion of astaxanthin in the total carotenoid of the present invention is as follows: HPLC chromatographic column: Eclipse XDB-C18, 5 μm, 4.6×150 mm; Mobile phase: methanol/water=95/5 (V/V); How rate: 1 ml/min; Column temperature: 25° C.; Detection wavelength: 478 nm.
The condition of determining chiral of astaxanthin of the present invention is as follows: chromatographic column: CHIRALPAK IC (0.46 cm×25 cm×5 μm); Mobile phase: ACN/MtBE=65/35 (v/v); How rate: 1 ml/min; Detection wavelength: 478 nm; Column temperature: 25° C.
Fifty (50) g (UV content is 10.5 wt %) of Adonis amurensis extract (Adonis amurensis extract is obtained by extracting Adonis amurensis dried granules with a mixture of propane and butane and then is volatilized) is added to 2500 ml of absolute ethanol, heated to 75° C. under stirring, and kept for 1.0 hr to fully dissolve the Adonis amurensis extract. Next, 432 ml of NaOH solution with 45% of the mass concentration (w/w) is added dropwise to form a reaction mixture solution, and the alkali concentration of the reaction mixture solution is 2.0 mol/L after completion of the addition, and stirred at 75° C. for 4.0 hr. Next, 5000 ml of deionized water and 1000 ml of ethanol are added to it, and then a dark red crystal is precipitated after slowly stirring for 1.0 hr. After filtration, the resulting filter cake is washed with a mixture of ethanol and deionized water (the ratio of ethanol to deionized water is 2:1) twice, 600 ml of the mixture of ethanol and deionized water per time, to obtain a crystal, and the crystal is dried in vacuum to eventually obtain 3.5 g of a dark purple carotenoid crystal.
Its maximum absorption wavelength of the carotenoid crystal by UV detection is at 470 nm, its content is 97.5 wt %, the ratio of astaxanthin analyzed by HPLC is 82.5 wt %, and 98 wt % of the astaxanthin according to chiral HPLC analysis is (3 S, 3′S) configuration, 2 wt % of the astaxanthin is (3S, 3′R)′ configuration.
At the same time, HPLC/MS analysis shows that there are all-trans astacene (6.81 wt %), and 9-cis semi-astacene and 13-cis semi-astacene (respectively 1.65 wt % and 1.65 wt %), as well as adonirubin (7.51 wt %), hydroxyechinenone (0.85 wt %) in the carotenoid crystal, besides all-trans astaxanthin. The total carotenoid composition in the crystal is shown in Table 1.
Also, as shown in Table 2, a relative content of each composition in the carotenoid crystal of the final product is changed by changing a proportion of solvent to amount of adding alkali, without changes of other conditions.
In comparative Example 1, due to the high concentration of alkali, part of the semi-astacene are oxidized into astacene, and proportion of adonirubin is also increased at the same time. It would be a reason to result in increasing the relative contents of other carotenoid after degradation of parts of astaxanthin. In comparative Example 3, the proportion of impurities such as semi-astacene, adonirubin are lower, and the proportion of all-trans astaxanthin is higher, because the alkali concentration is too low, there are still a large part of raw material not to have reacted completely after 6 hr and the yield of the final product is low.
100 g of Adonis amurensis extract (UV content is 10.5 wt %) is added to 3000 ml of glycerol, heated to 60° C. under stirring, and kept for 1.0 hr to fully dissolve the Adonis amurensis extract. 1000 ml of CH3ONa solution with the mass concentration of 25% (w/w) is added dropwise to form a reaction mixture solution, and the alkali concentration of the reaction mixture solution is 1.16 mol/L, and stirred at 60° C. for 0.5 hr. 6000 ml of deionized water and 1000 ml glycerol is added to it, and then a dark red crystal is precipitated after slowly stirring for 1.0 hr. After filtration, the filter cake is washed with a mixture of glycerol and deionized water (the ratio of glycerine and deionized water is 3:1) for twice, 500 ml of the mixture of glycerol and deionized water per time, to obtain a crystal, the crystal is dried in vacuum, to eventually obtain 4.8 g of a dark purple carotenoid crystal.
Its maximum absorption wavelength of the carotenoid crystal by UV detection is at 470 nm, its content is 98.2 wt %, the ratio of astaxanthin analyzed by HPLC is 87.1 wt % and 97 wt % of the astaxanthin according to chiral HPLC analysis is (3 S, 3′S) configuration, 3 wt % of the astaxanthin is (3S, 3′R)′ configuration.
At the same time, HPLC/MS analysis shows that there are all-trans atacene (3.81 wt %), and 9-cis semiastacene and 13-cis semiastacene (respectively 1.01 wt % and 0.26 wt %), as well as adonirubin (5.81 wt %), hydroxy echinenone (0.75 wt %) in the carotenoid crystal, besides all-trans astaxanthin. The total carotenoid composition in the crystal is shown in Table 3.
100 kg adonis amurensis extract (UV content is 10.5 wt %) is added to 5000 L of propylene glycol, and is fully dispersed under stirring at 25° C. 123 L of KOH solution with a mass concentration of 25% (w/w) is added dropwise, and is stirred at 25° C. for 2.5 hr. After sampling and analysis with HPLC, it is found that the reaction is not complete, and the reaction is continued for 3.5 hr. After completion of the reaction monitored by HPLC, 5000 L of deionized water and 500 L of propylene glycol are added to it to terminate the reaction. After stirring slowly for 1.0 hr, a dark red crystal is precipitated. After filtration by pressure, a filter cake is washed with a mixture of propylene alcohol and deionized water (the ratio of propylene alcohol to water is 2:1) twice, 600 ml of the mixture of propylene alcohol and deionized water per time, to obtain a crystal, the crystal is dried in vacuum, to eventually obtain 6.8 Kg of a dark purple carotenoid crystal.
Its maximum absorption wavelength of the carotenoid crystal by UV detection is at 470 nm, its content is 94.9 wt %, the ratio of astaxanthin analyzed by HPLC is 87.4 wt %, and the 91 wt % of astaxanthin according to chiral HPLC analysis is (3 S, 3′S) configuration, the 9 wt % of astaxanthin is (3S, 3′R)′ configuration.
At the same time, HPLC/MS analysis shows that there are all-trans atacene (5.23 wt %), and 9-cis semiastacene and 13-cis semiastacene (separately 0.85 wt % and 0.23 wt %), as well as adonirubin (4.32 wt %), hydroxy echinenone (0.68 wt %) in the carotenoid crystal, besides all-trans astaxanthin. The total carotenoid composition in the crystal is shown in Table 4.
It may be seen from it that a mixture solution of alcohols solvent and water is added to terminate the reaction after completion of the reaction of the present invention, and the content of the total carotenoid and the proportion of astaxanthin of the final products can be adjusted by adjusting the proportion and the total amount of alcohols solvent and water. The more the usage of the mixture solution is, the higher the percentage of the alcohols solvent is, and then the higher the total carotenoid content in the final product is, and the higher the proportion of astaxanthin is But it affects the yield of final products.
Carotenoid is a kind of liposoluble dietary component and is often combined with lipoproteins in human blood. So carotenoid is mixed with a small amount of vegetable fat when orally administered, or is used with food containing a certain amount of grease when oral administered. It will greatly enhance absorption and bioavailability of the carotenoid. Carotenoid is mixed with modified starch and grease, and then emulsified and dispersed to obtain nanoscale particles, and afterwards embedded by common microcapsule emulsion technology in order to obtain astaxanthin. It can not only improve the stability of carotenoid, but also improve the absorption and bioavailability in vivo.
We have developed the following two dosage forms as follows by using the carotenoid crystal containing natural astaxanthin obtained from Example 2.
(1) 55 g of the carotenoid compound crystal containing natural astaxanthin are adequately grinded to make particles with 3 μm of particle size, and then mixed with 200 g of olive oil under stirring to make particles uniformly dispersed to obtain an oil suspension. The content of the total carotenoid of the oil suspension is 20 wt %, wherein natural astaxanthin is 175 mg/g. After filling with nitrogen and packaging closely, the change of the total carotenoid and astaxanthin in the oil suspension is monitored by UV and HPLC. The content of the effective ingredient of the oil suspension is stability after one month. This oil suspension containing natural astaxanthin can be administered in the form of soft capsules.
(2) 200 g of the carotenoid compound crystal containing natural astaxanthin is mixed with modified starch and sucrose to prepare water-soluble microcapsule particles containing astaxanthin according to the method of CN101177540B. It may be found that the microcapsule particles have good stability, and the retention rate is higher than 95% in case of airtight package and storied at 40° C. for two years. It is shown from assays in vitro that the bioavailability of the microcapsule particles is increased nearly tenfold in comparison with the astaxanthin crystal. The microcapsule particles containing natural astaxanthin can be administered in the form of tablets or capsules.
It can be seen from the above Examples that the high content carotenoid crystal from Adonis amurensis are firstly illustrated in the present invention, wherein the high content carotenoid crystal contains a large amount of all trans (3 S, 3 S)-astaxanthin and a small amount of semi-astacene, astancene, adonirubin and trace amounts of other carotenoids. The carotenoid may exist in dietary ingredients, and can be detected in human blood. This kind of carotenoid crystal has high purity, and can be used in multiple forms in the fields of dietary supplements for human beings, food additives, feed additives and cosmetic products. The present invention also provides a method of preparing the high-content carptenoid compound from Adonis amurensis with simple and reliable, suitable for industrial production.
The present invention illustrates by the above examples, however, it is understood that, the present invention is not limited to special instance and implementation scheme described herein. Here the purpose including these special instances and implementation schemes is aimed at helping the persons skilled in the art to achieve this invention. It is easy for any persons skilled in the art to carry out further improvement and perfection not from the spirit and scope of the invention, so the present invention is just limited by the content and scope of the claim of the present invention, its intention to cover all included all alternative solutions and equivalent solutions within the spirit and scope of the present invention limited by the appendix claims.
| Number | Date | Country | Kind |
|---|---|---|---|
| 201310440119.6 | Sep 2013 | CN | national |
This application is a national phase application of PCT/CN2014/000862, filed on Sep. 23, 2014, which claims priority to Chinese Application No. 201310440119.6 filed on Sep. 24, 2013.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/CN2014/000862 | 9/23/2014 | WO | 00 |
